State-of-the-art: Standards can limit creativity, but recent studies have established that potential drawbacks are outweighed by the benefits along the innovation process (Tassey, 2000) . In the past, research in standardization has often focused on compatibility of new products from a market perspective (Farrell and Saloner, 1985) . In particular, attention has been paid to formal standards by standard setting organizations (SSO) as well as information and communications technology markets (Simcoe et al., 2009) . Standards consortia and company standards have been investigated as additional types of standards (Leiponen, 2008) . With regard to basic research, standardization is regarded as a catalyst which facilitates technology transfers (Bozeman, 2000) . However, few studies have examined the interdependencies between standardization and research (Blind and Gauch, 2009 ).
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ABSTRACT
In the past, research in standardization has often focused on compatibility of new products from a market perspective. With regard to basic research, standardization is regarded as a catalyst which facilitates technology transfers, but few studies have examined the interdependencies between standardization and research. It remains to be resolved what drives standardization and who is involved in standardization along the research process. This paper investigates the characteristics of standards which assist technology transfers in biotechnology. We point out that the biotechnology industry relies on evolving standards in early research stages and continuous adoption to the technological progress. Despite recent findings with regard to formal standards linked to commercialization we show that community-driven standards are a complementary standardization tool which is mainly used in basic research. Furthermore, we find that within basic research articles related to standards are used more often than their closest peer group in terms of forward citations. In addition, the negative binomial model reveals that especially interface standards are most valuable to future research.
INTRODUCTION
The fundamental purpose of standards is to enable interoperability and coordination.
Standards arguably limit creativity in the innovation process, but recent studies have established that potential drawbacks of standards are outweighed by the benefits (Allen & Sriram, 2000; Tassey, 2000; Temple, Blind, Jungmittag, Spencer, & Witt, 2005) . Standards reduce the costs of innovating by narrowing the set of product differentiations while promoting interdependent research tasks (Baldwin & Clark, 2000) . With regard to the innovation process as a whole, standardization is regarded as a catalyst which facilitates technology transfers (Bozeman, 2000) .
In the past, research in standardization has often focused on compatibility of new products from a market perspective (Farrell & Saloner, 1985) . Most attention has been paid to formal standards by standard setting organizations (SSO) as well as information and communications technology markets (Simcoe, Graham, & Feldman, 2009) . However, few studies have investigated the interdependencies between standardization and research (Blind & Gauch, 2009; Zi & Blind, 2013) .
Interoperability and coordination of research activities is of particular importance in industries which rely on different disciplines, technologies and skills such as the biotechnology industry (Gillis, 2003) . Especially due to the vastly increasing amount of data the research community has recognized the need for efficient standards for several years (Almeida et al., 2006; Quackenbush, 2006; Wang, Gorlitsky, & Almeida, 2005) . However, until today there exist no international standards by standard-setting organizations (SSO) in biotechnology.
The German Institute for Standardization (DIN) recently proposed the establishment of a technical committee (TC) at the International Organization for Standardization (ISO) with respect to biotechnology (Lonien, 2012) , but, so far, no progress could be accomplished. In for Standardization (CEN) in three particular subfields of Biotechnology. However, these standards are mostly generic and limited to large-scale production, performance criteria and criteria for reaction vessels. Therefore, they are of little relevance to the industry, e.g.
DIN EN 1619
states "before putting to use, they [working cell banks] should be characterized with an appropriate degree of accuracy" without further specifying the appropriate degree of accuracy.
Industry experts have pointed out that informal standards might be more suited to the needs of biotechnology as traditional patterns of standardization do not work (Rai, 2010 The question arises, which necessities are current efforts of standardization in biotechnology confronted with. As standardization in the beginning of the innovation process has re-ceived little attention, this paper investigates the properties of standards at the research stage of the innovation process as well as how these standards assist technology transfers at the example of the biotechnology industry. Furthermore, we examine who is involved in standardization along the research process; whether standardization is driven by top researchers or rather by practitioners. The aim of the study is to gain a better understanding of the role of standardization along the research process.
PROPERTIES OF STANDARDS IN RESEARCH
Standards procure the diffusion of technology, as part of the innovation system (Besen & Farrell, 1994) . This matter nourishes and creates value for the R&D process as well as other investments in knowledge creation (Temple et al., 2005) . Overall, standards are a source of relevant information to opinion leaders in the innovation system. This implies that the research community as well as the standards community constantly monitor, alert, and match standardization efforts. On the one hand, the research community pulls information for research and pushes information on standardization. On the other hand, the same holds true vice versa for the standards community. In order to understand the interdependencies we need to define the properties of standards in research as well as the relation between research and standards communities.
So far, the literature differentiates between three categories of standards. First of all, formal standards are established by SSOs such as ISO or CEN. Formal standardization follows a strict procedure which is transparent to the stake holders and guarantees a high level of consensus, but can also be tedious and costly. Furthermore, consortia standards and company standards have been specified as additional categories of standards (Blind & Gauch, 2008; Leiponen, 2008) . In contrast to formal standards, they evolve from an exclusive group or arrangement. Therefore, not all interests of all stake holders are always considered and lower Michael Raven -Working paper 5 levels of consensus are achieved. The main advantages are the faster development cycles as well as the general flexibility of these types of standards.
Deriving from contingency theory, an efficient standardization process adopts to the environmental conditions. If we combine what we know about biotechnology and standards, we can hypothesize that early research stages in biotechnology benefit from evolving standards with continuous adoption to the technological progress, which is neither served by SSOs nor by standards consortia.
In our analysis, we define an alternative category of standards which has not been described in the literature beforehand and can be found in an online-platform of biotech standards named BioSharing. The origin of BioSharing lies in the United Kingdom in 2009. In total, 35 community members, mainly research communities, but also the DIN, contribute to the platform. BioSharing is free of charge. Everybody can register and contribute to the platform.
The mission of BioSharing is to "serve those seeking information on existing standards, but also to […] promote harmonization to stop wasteful reinvention." Thereby, the platform provides community-driven standards which combine benefits of formal standards as well as company and consortia standards. In analogy to formal standards, community-driven standards are transparent and easily accessible, but at the same time they are flexible and require only short development times similar to company and consortia standards. In analogy to the formation of consortia, community standards are based on coalition theory (Olson, 1971 ). Blind and Gauch (2007) have pointed out the obstacles for researchers to engage in standardization, although standards ought to evolve in parallel to the research process. With regard to the content of standards in the research process they differentiate between three types of standards: Firstly, after pure basic research semantic standards have to be established in order to define a clear terminology. The definition of terms is necessary in order to enable the communication between researchers, product and process developers. Secondly, after oriented basic research, measurement and testing standards are a prerequisite for the verification of product development. For example, agreements about minimum information guidelines ensure that cartilage cells are identified across project and country boundaries. Thirdly, interface standards mediate the progress from applied research to experimental development. For example, research projects in biotechnology often deal with interfaces when partial research results ought to be integrated into an all-embracing database or a complex overall model. Afterwards, compatibility and quality standards facilitate the diffusion of new products, but will not be discussed in greater detail in this paper.
Within the BioSharing platform standards are classified according to "terminology artifact", "reporting guidelines", and "exchange format". In combination with key words such as "ontology" for semantic standards, "minimum information" for measurement and testing standards, and "File XXX" for interface standards an accurate matching with regard to the content of the standards was ensured. Overall, 64.5% of the standards in BioSharing refer to semantic standards, 11.6% of the standards deal with measurement and testing standards, and 24.9% of the standards define interface standards. Biotechnology being a rather new scientific discipline it comes as no surprise that the majority of standards address terminology issues.
Furthermore, the development of high-throughput-screening and next-generation-sequencing have increased the need for interface standards dealing with complex databases.
THE LINK BETWEEN STANDARDIZATION AND RESEARCH
Research findings about formal standards suggest that standards play an increasing role as In spite of the above mentioned research findings, there is also a line of arguments in favor of rejecting the first hypothesis. In a related research field, it is established that patenting researchers are more successful in publishing (Agrawal & Henderson, 2002; Czarnitzki, Glänzel, & Hussinger, 2007 Stephan, Gurmu, Sumell, & Black, 2007; Van Looy, Callaert, & Debackere, 2006) . In analogy to the field of patents, standardization activities arguably circulate relevant knowledge and are beneficial for those who seek knowledge. Therefore, one can also argue the higher the R&D intensity, the higher the knowledge sourcing benefits from standardization.
From the general definition of standards we can derive that standards avoid misconceptions in joint research projects. Through the unification of methods in subsequent research efforts scientists can be more productive. Consequently the online-platform BioSharing has pointed out in its mission to stop wasteful reinventions. Therefore, we argue in our second hypothesis that standards are an essential element for research progress. Thus, articles with regard to standards are used more often than comparable articles. As an operationalization of the first hypothesis we compare the arithmetic mean of the impact factors of the journals which publish standards to the arithmetic mean of journals in biotechnology where the `Journal Citation Reports´ by Thomson Reuters provide a peer group of biotechnology journals. Thereby, we assume that journals in basic research have higher impact factors than more applied journals which relate to more market-oriented research (Garfield, 1972 (Garfield, , 2006 .
With regard to the operationalization of the second hypothesis we differentiate between publications directly linked to standards and publications using these standards publications:
Each publication linked to a standard in BioSharing is matched to the most-related article in the same volume of the same journal using a search algorithm developed by the National Library of Medicine (NLM) in order to constitute a meaningful control sample (Furman & Michael Raven -Working paper 9 Stern, 2011). As a robustness check, a second control sample is constituted on the basis of the most-related article without taking the volume and the journal into account.
Either forward citations in the first year after publication, forward citations in year t, or cumulative forward citations since publication serve as dependent variables (Garfield, 1979) . Table 1 provides an overview of the information for the dependent variables. Average Forward Citations j1 to articles in the same journal with t=1
Journal Citation Reports
With regard to the independent variables we introduce a dummy variable `standard article´ which differentiates between articles related to standards and the control group. In a more sophisticated model we further differentiate between the three different types of standards.
The article title is used as an identifier across the different databases. Furthermore, we stepwise extend the model by controlling for the publication year, the number of authors, the top 50 universities, and the journal category. Table 2 provides an overview of the information for the independent variables. An investigation of the descriptive statistics differentiated by the control group already provides a good overview about the empirical findings. On average, standard articles are cited 2.8 times more often than control articles. Noticeable is that also 2.9 times more authors per publication are involved with standard articles in comparison to control articles (Table 4) . As previously done for patents (Mehta, Rysman, & Simcoe, 2010) , the citation age profile for standards illustrates the diffusion of standards compared to control articles over time (Figure 4) . In general, standard articles are cited significantly more often than control articles.
Noteworthy is that standard articles also pursue a different time trend than the control articles.
In the first two years, forward citations to both groups rise, while standard articles receive more forward citations. However, in the second year after publication, the control articles reach a maximum and subsequently decline. In contrast, standard articles reach their maximum in the third year after publication and continue to stay at a relative high level, although we have to point out that after six years the confidence interval dramatically increases due to the lack of available data. The intervals around the median show the 90 percent confidence intervals and are constructed according to Conover (1980) . 
RESULTS
With regard to the first hypothesis we find that standards in our database are linked to journals with an aggregated one-year impact factor of 10.07 (median impact factor: 5.32). In comparison, a control group of biotech journals reported by the `Journal Citation Reports´ (JCR) shows an aggregated one-year impact factor of 3.78 (median impact factor: 2.47).
Given the 95 percent confidence intervals, we can conclude that standards are significantly more likely to publish in biotechnology journals with higher impact factors ( Table 5 ).
Assuming that higher impact factors relate to basic research (Garfield, 1972 (Garfield, , 2006 , we retain that community-driven standards are crucial in early research activities. Therefore, community standards can be regarded as complementary standardization tools in view of the mainly market-driven usage of formal standards and hypothesis 1 must be disregarded. compare forward citations in the first year after publication of standard articles with average forward citations to articles in the same journal. A paired t-test shows at the 1 percent significance level that standard articles receive on average one and a half times more forward citations in the first year than articles in the same journal. Since the standard articles are also included in the average forward citations to the journal and we only consider the first year after publication, this test can be regarded as a very conservative test. In a second step, we expand the paired t-test by comparing cumulative forward citations of standard articles with most-related articles published in the same journal in the same volume. The paired t-test reveals at the 1 percent significance level that standard articles receive on average 2.8 times more forward citations than the control group over the entire lifetime of a publication. As the paired t-test relies on a normal distribution we have to review the robustness of the above mentioned results. Therefore, we use a Wilcoxon signed rank sum test as non-parametric robustness check (Hollander & Wolfe, 1973) . The Wilcoxon test for the difference in means without any assumption about the distribution remains significant at the 5% significance level.
Although one can argue that normal distribution is a reasonable assumption for cumulative forward citations, figure 3 in the previous chapter clearly demonstrates that the assumption does not hold true for forward citations on a yearly basis. Therefore, we cannot use an ordinary least square regression model, but have to account for the characteristics of count data by applying a poisson model or a negative binomial model. Since we are confronted with over-dispersed count data, i.e. the conditional variance is larger than the conditional mean, we have chosen a negative binomial model over a poisson model in analogy to Furman & Stern (2011) . However, all reported results also hold true in a poisson model at the same level of significance or even higher.
Our baseline model identifies the effect of a standardization article on yearly forward citations. Therefore, the first model estimates the following equation:
The first column of table 6 reports the results for the baseline model. A significant positive coefficient implies a positive relation between independent variable and forward citations. A positive coefficient translates into an incidence-rate ratio greater than one while a negative coefficient translates into an incidence-rate ratio smaller than one. Specifically, standard articles receive 2.781 more forward citations than most-related articles. The intersection with the y-axis is statistically significant accounting for the fact that also the control articles receive forward citations. However, the pseudo R² value shows that the baseline model only has limited explanatory power. As an extension of the baseline model we account for conditional fixed effects over time.
Namely, dummy variables are included for each article pair (Allison & Waterman, 2002; Hausman, Hall, & Griliches, 1984) . Furthermore, we have already reported in figure 4 that at least in the first years after publication citations rise over time. Therefore, we also include the age of the publication in the model. In addition, the summary statistics have shown that on average more authors are involved in standard articles than in control articles. This comes as no surprise as standards require a level of consensus which is more likely to be achieved if many authors are involved in the publication process. However, researchers are also more likely to cite their own publications in future research than random articles. Therefore, we have to disentangle the effect of the standardization from the self-citing effect, i.e. more authors involved in standard articles are more likely to self-cite the standard articles. The following equation follows for the second model: However, the disproportionately high number of authors in standard articles are not accountable for the overall standardization effect. In contrast to the first model, the intersection with the y-axis is not significant anymore, but the explanatory power of the extended model has increased up to 17.3 percent. Overall, the alpha test for all three model specifications is significant at the one percent level. Thus, the overdispersion of the data is confirmed and the application of a negative binomial model is reinforced.
DISCUSSION
In a first step we have recognized a new kind of standardization process in our database. In contrast to SSOs, standards consortia, and corporate standards, our database contains of community driven standards. They combine benefits of formal and informal standards since standardization in its traditional form cannot properly address the current needs of the biotechnology industry. Community-driven standards allow for an open and transparent, but still adjustable and quickly developed standardization process.
Based on the above mentioned findings we reject the first hypothesis. On the contrary, the relative meaning of standards in publications suggest that standardization is highly relevant to basic research in biotechnology. This finding supports the line of argument that standards serve as a crucial source of information for basic researchers. Instead of limiting standardization to market-oriented challenges our paper points out a complementary standardization tool which serves the needs of basic research.
Our empirical results confirm the argument of the second hypothesis. Standards are essential elements of basic research. Thus, they are cited more often than their peer group. The focus of our study on the biotechnology industry allows us an in-depth analysis of the research questions without any confusion due to different industry backgrounds. As a shortcoming of such a specific data sample generalizability of the results might be questionable.
However, standardization in the biological sciences requires flexible, easily accessible, and quickly developed standards due to a rapidly changing technology basis and multidisciplinary challenges. We assume that many other high-tech industries have to comply with these requirements and our results can be transferred to other industries.
Further potential limitations of our study arise with regard to our data sample. First of all, approximately 20 percent of the standards in the BioSharing database are linked to research articles while -potentially due to a bias -80 percent of the standards are not linked to a par- 
